SFM
NVO

Sphera Funds Management’s Novo Nordisk NVO Stock Holding History

Sphera Funds Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.43M Buy
120,677
+5,000
+4% +$237K 0.7% 51
2025
Q4 		$5.89M Buy
115,677
+10,000
+9% +$511K 1.14% 35
2025
Q3 		$5.86M Hold
105,677
– – 1.24% 22
2025
Q2 		$7.29M Sell
105,677
-12,403
-11% -$844K 1.71% 13
2025
Q1 		$8.2M Buy
118,080
+20,000
+20% +$1.65M 1.89% 13
2024
Q4 		$8.44M Buy
98,080
+20,000
+26% +$2.16M 1.53% 18
2024
Q3 		$9.3M Hold
78,080
– – 1.48% 19
2024
Q2 		$11.1M Sell
78,080
-5,000
-6% -$663K 1.52% 20
2024
Q1 		$10.7M Sell
83,080
-10,000
-11% -$1.19M 1.5% 23
2023
Q4 		$9.63M Hold
93,080
– – 1.55% 20
2023
Q3 		$8.46M Sell
93,080
-20,000
-18% -$1.76M 1.54% 15
2023
Q2 		$9.15M Sell
113,080
-30,000
-21% -$2.45M 1.43% 15
2023
Q1 		$11.4M Hold
143,080
– – 1.9% 12
2022
Q4 		$9.68M Sell
143,080
-449,800
-76% -$26.4M 2.08% 12
2022
Q3 		$29.5M Buy
592,880
+70,000
+13% +$3.75M 4.1% 7
2022
Q2 		$29.1M Buy
522,880
+48,080
+10% +$2.67M 3.12% 9
2022
Q1 		$26.4M Buy
+474,800
New +$24.4M 3.73% 8
2020
Q3 		– Sell
-800,000
Closed -$26.2M – 108
2020
Q2 		$26.2M Sell
800,000
-352,000
-31% -$11.2M 2.46% 11
2020
Q1 		$34.7M Sell
1,152,000
-128,000
-10% -$3.81M 4.34% 8
2019
Q4 		$37M Buy
1,280,000
+380,000
+42% +$10.5M 3.05% 7
2019
Q3 		$23.3M Buy
+900,000
New +$22.8M 3.59% 8
2019
Q2 		– Sell
-800,000
Closed -$20.9M – 106
2019
Q1 		$20.9M Buy
+800,000
New +$19.7M 1.91% 12

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Sphera Funds Management's NVO Position: Q1 2026 in Review

Sphera Funds Management increased its Novo Nordisk (NVO) stake by 4.3% in Q1 2026, buying an estimated $237K and bringing the position to 120,677 shares worth $4.43M. The position accounts for 0.7% of the portfolio, ranked #51.

Sphera Funds Management first reported a position in NVO in Q1 2019 and has held it in 22 quarters since. The position peaked at $37M in Q4 2019. 1,271 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Sphera Funds Management held 120,677 shares of Novo Nordisk worth $4.43M as of Q1 2026.
  • Sphera Funds Management bought 5,000 Novo Nordisk shares in Q1 2026, an estimated $237K.
  • Novo Nordisk made up 0.7% of Sphera Funds Management's portfolio in Q1 2026, its #51 holding.
  • Sphera Funds Management first reported a position in Novo Nordisk in Q1 2019 and has held it in 22 quarters since.
  • Sphera Funds Management's Novo Nordisk position peaked at $37M in Q4 2019.
  • 1,271 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Sphera Funds Management's 13F filing for Q1 2026, filed 15 May 2026.